Molecular Templates to Present at Upcoming Investor Conferences
AUSTIN, Texas, May 17, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (ETBs), will participate in the following upcoming investor conferences.
Details can be found below:
Webcast links for the presentations will be posted on the “News & Media” section of the Molecular Templates corporate website, under Events.
About Molecular Templates
Source: Molecular Templates, Inc.